- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.62 BnMarket Estimate, 2026
$3.91 BnMarket Forecast, 2034
$7.24 BnCAGR, 2026–2034
8.00%European Syringes Market Size, Growth, Trends & Forecast (2026–2034)
The European syringes market size was valued at USD 3.62 billion in 2025, is anticipated to reach USD 3.91 billion in 2026, and is projected to scale up to USD 7.24 billion by 2034, registering a compound annual growth rate (CAGR) of 8.00% during the forecast period from 2026 to 2034. Driven by surging demand for prefilled syringes, growing government healthcare investments, rising incidence of chronic and pandemic diseases (e.g., diabetes, cardiovascular issues), and continuous immunization drives, the European syringe manufacturing and medical device sector continues to expand rapidly.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 3.62 Billion
- 2026 Current Valuation: USD 3.91 Billion
- 2034 Forecast Valuation: USD 7.24 Billion
- Compound Annual Growth Rate (CAGR): 8.00% (2026–2034)
- Dominant Regional Markets: United Kingdom (largest regional market) and Germany (major mass-producer and world's largest syringe exporter)
- Fastest-Growing Country / Sector: Russia (notable growth in insulin syringes and healthcare infrastructure demand)
Core Market Drivers
- Chronic Diseases & Aging Population: High prevalence of diabetes and cardiovascular illnesses increasing the clinical reliance on regular injections.
- Technological & Product Innovations: Expanding use of prefilled syringes, safety needles, and specialized biologics/Botox therapeutics.
- Immunization Campaigns: Ongoing vaccination initiatives and surgical procedures boosting baseline product consumption across Europe.
Primary Market Restraints & Challenges
- Alternative Delivery Systems: Proliferation of alternative drug-delivery tools such as insulin pens for diabetic patients.
- Operational Obstacles: Manufacturing labor shortages, risks of needlestick injuries, and stringent regulatory compliance hurdles.
European Syringes Market Segmentation Breakdown
| Segment Category | Sub-Segment Scope & Details |
|---|---|
| By Usability | Sterilizable/Reusable (Hypodermic, Oral) & Disposable Syringes (Conventional, Safety, Prefilled) |
| By Material | Glass Syringes & Plastic Syringes |
| By Type | General Syringes & Specialized Syringes (Insulin, Tuberculin, Allergy, and Others) |
| By Country | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe |
Major Industry Players Profiled
Key companies operating in the European syringes market include Terumo Corporation, B. Braun Medical Inc., Medtronic plc, Becton, Dickinson and Company, Smiths Medical, NIPRO Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.
Europe Syringes Market Size
The European syringes market size was valued at USD 3.62 billion in 2025 and is anticipated to reach USD 3.91 billion in 2026 from USD 7.24 billion by 2034, growing at a CAGR of 8.00% during the forecast period from 2026 to 2034.
The increased demand for syringes and technological developments in the manufacturing of syringes are majorly propelling the growth of the European syringes market. Growing investments from the EU governments to enhance the healthcare ecosystem; the growing incidence of chronic and pandemic diseases such as diabetes, infectious diseases, and cardiovascular diseases across Europe is demanding more production of syringes, which is boosting the market growth. In addition, the increasing patient population needs more and more syringes for treatment procedures, further promoting product demand. Furthermore, private and government investments in research and development facilities are anticipated to create growth opportunities.
Furthermore, the market is also driven by the increased use of prefilled syringes and injectable medications and growing demand for Botox therapeutics purposes. Due to the increased use of advanced technology and numerous products that benefit end consumers, the European syringes market is expected to grow. In addition, YOY's growth in surgical procedures, vaccination, and immunization drive against viruses such as COVID-19, typhoid, and others are expected to offer substantial growth possibilities to the market in this region.
On the other hand, the European syringes market is estimated to be hampered by the availability of alternative drug delivery techniques, such as the insulin pen used to inject insulin in diabetic patients. In addition, the market faces substantial obstacles, including a shortage of qualified workers in the manufacturing area and an increase in the number of needlestick injuries.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 8% |
| Segments Covered | By Usability, Material, Type and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, the Netherlands, Turkey, and the Czech Republic |
| Market Leaders Profiled | Terumo Corporation, B. Braun Medical Inc., Medtronic plc, Becton, Dickinson and Company, Smiths Medical, NIPRO Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG. |
REGIONAL ANALYSIS
Geographically, the European syringes market held a substantial share in the global market in 2025 and is majorly driven by improved technology in medical testing facilities and government programs that provide funding. In addition, most syringes and needles in Europe are sold individually and combined as needed. However, some particular markets, such as Italy, where strong sales of pre-attached syringes and needles make the stand-alone market modest in comparison.
The UK syringes market was the largest regional market in Europe and is expected to remain so throughout the forecast period.
The syringes market in Germany is anticipated to grow considerably during the forecast period. Germany is known for developing and mass-producing innovative new syringes. As a result, Germany is the world's largest syringe exporter, accounting for 8.69 percent of syringes sent to industrialized countries. In the German syringe market, B. Braun, Melungen AG, Schott AG, and Gerresheimer AG have most of the market share.
Regarding healthcare infrastructure and the pharmaceutical industry, Russia is the fastest-growing country. Russia has the most significant market share for insulin syringes. Diabetic patients are becoming more common in the country, fueling market expansion. Insulin syringes and shipments are imported into Russia. However, Russia's low costs and strict restrictions on local syringe exchange hampered the market growth. By focusing on drug injectors, pharmacy-based syringe distribution and exchange will assist in enhancing the cost-effectiveness of HIV prevention.
KEY MARKET PLAYERS
A few of the prominent companies operating in the European syringes market include
- Terumo Corporation
- B. Braun Medical Inc.
- Medtronic plc
- Becton, Dickinson and Company
- Smiths Medical
- NIPRO Corporation
- Gerresheimer AG
- Hindustan Syringes & Medical Devices Limited
- SCHOTT AG
- CODAN Medizinische Geräte GmbH & Co KG
MARKET SEGMENTATION
This research report on the European syringes market has been segmented and sub-segmented into the following categories
By Usability
- Sterilizable/reusable
- Hypodermic
- Oral
- Disposable Syringes
- Conventional
- Safety
- Prefilled
By Material
- Glass Syringes
- Plastic Syringes
By Type
- General Syringes
- Specialized Syringes
- Insulin
- Tuberculin
- Allergy
- Others
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe